[1]宋卫东,赵庆忠,蔡 波,等.益气活血化痰汤、无创双水平气道正压通气联合纳美芬治疗老年慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭疗效研究[J].陕西中医,2023,(4):455-458.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.010]
　SONG Weidong,ZHAO Qingzhong,CAI Bo,et al.Clinical of Yiqi Huoxue Huatan decoction,non-invasive bi-level positive airway pressure ventilation combined with nalmefene in the treatment of COPD combined with type Ⅱ respiratory failure in elderly patients[J].,2023,(4):455-458.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.010]
点击复制

益气活血化痰汤、无创双水平气道正压通气联合纳美芬治疗老年慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年4期
页码:
455-458
栏目:
临床研究
出版日期:
2023-04-05

文章信息/Info

Title:
Clinical of Yiqi Huoxue Huatan decoction,non-invasive bi-level positive airway pressure ventilation combined with nalmefene in the treatment of COPD combined with type Ⅱ respiratory failure in elderly patients
作者:
宋卫东; 赵庆忠; 蔡 波; 万 健
(上海市浦东新区人民医院,上海 201299)
Author(s):
SONG Weidong; ZHAO Qingzhong; CAI Bo; WAN Jian
(People's Hospital of Pudong New Area,Shanghai 201299,China)
关键词:
慢性阻塞性肺疾病;  呼吸衰竭;  益气活血化痰汤;  纳美芬;  无创双水平气道正压通气;  肺功能
Keywords:
Chronic obstructive pulmonary disease;  Respiratory failure;  Yiqi Huoxue Huatan decoction;  Nalmefene;  Noninvasive bi-level positive airway pressure ventilation;  Lung function
分类号:
R 563.8
DOI:
DOI:10.3969/j.issn.1000-7369.2023.04.010
文献标志码:
A
摘要:
目的:探究益气活血化痰汤、无创双水平正压通气联合纳美芬治疗慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭疗效及对患者肺功能、肺部活化调节趋化因子(PARC/CCL18)水平的影响。方法:选取152例老年COPD合并Ⅱ型呼吸衰竭患者,随机分为观察组和对照组,每组76例。两组患者均采用常规解痉、祛痰、抗感染、水电解质平衡等对症治疗和无创双水平气道正压通气,对照组给予纳洛酮治疗,观察组患者另给予益气活血化痰汤、纳美芬治疗,对比两组血气指标、肺功能指标、血清肺表面活性相关蛋白D(SP-D)、PARC/CCL18水平及临床疗效。结果:治疗前两组患者动脉血氧分压(PaO2)、二氧化碳分压(PaCO2)、血氧饱和度(SaO2)、心率及呼吸频率、肺功能、SP-D、PARC/CCL18比较差异无统计学意义(P>0.05)。治疗后观察组患者血气指标水平均优于对照组(P<0.05); 治疗后观察组患者心率、呼吸频率、收缩压(SBP)、舒张压(DBP)优于对照组(P<0.05); 治疗后观察组患者肺活量为50%时的呼气流速(PEF50)、第1秒末用力呼气量(FEV1)、最大呼气压(PEmax)、肺总容量(TLC)均优于对照组(P<0.05); 治疗后,观察组患者血清SP-D、PARC/CCL18水平低于对照组(P<0.05)。观察组总有效率高于对照组(P<0.05)。结论:益气活血化痰汤、无创双水平气道正压通气联合纳美芬可有效改善COPD合并Ⅱ型呼吸衰竭老年患者的肺功能、血气指标,降低血清SP-D和PARC/CCL18水平。
Abstract:
Objective:To observe the clinical efficacy of Yiqi Huoxue Huatan decoction,non-invasive bi-level positive airway pressure ventilation combined with nalmefene in the treatment of COPD combined with type Ⅱ respiratory failure in elderly patients.Methods:A total of 152 elderly patients with COPD combined with type Ⅱ respiratory failure were selected as the study subjects and randomly divided into observation group and control group,76 cases in each group.Both groups were treated with conventional spasmodic,expectorant,anti-infection,water and electrolyte balance and other symptomatic treatments as well as non-invasive bi-level positive airway pressure ventilation.The control group was additionally given naloxone injection treatment on the basis of the above,and the observation group was additionally given Yiqi Huoxue Huatan decoction and nalmefene injection.The blood gas indexes,lung function indexes,SP-D,PARC/CCL18 levels and clinical efficacy of the two groups before and after treatment were observed and compared.Results:There were no significant differences in PaO2,PaCO2,SaO2,heart rate and respiratory rate,lung function,SP-D,PARC/CCL18 between the two groups before treatment(P>0.05).After treatment,the blood gas index level of observation group was better than control group(P<0.05).After treatment,heart rate,respiratory rate,SBP,DBP in observation group were better than those in control group(P<0.05).After treatment,PEF50,FEV1,PEmax and TLC in observation group were better than those in control group(P<0.05).After treatment,the serum levels of SP-D and PARC/CCL18 in the observation group were better than those in the control group(P<0.05).The total effective rate of observation group was higher than that of control group(P<0.05).Conclusion:Yiqi Huoxue Huatan decoction,noninvasive bi-level positive airway pressure ventilation combined with nalmefene can effectively relieve the clinical symptoms of elderly patients with COPD combined with type Ⅱ respiratory failure,better improve the lung function and blood gas indexes of patients,and reduce the levels of serum SP-D and PARC/CCL18.

参考文献/References:

[1] 杨浩辉,刘 斌,李炳翰,等.丁苯酞对帕金森病伴抑郁小鼠黑质纹状体NLRP3和IBA-1表达的影响[J].实用老年医学,2022,36(7):670-674.
[2] 史 磊,张 叶,王 亚.丁苯酞软胶囊联合盐酸多奈哌齐对帕金森病患者血清PARK7、CRP、NT-3水平及认知功能的影响[J].反射疗法与康复医学,2022,3(10):129-131,139.
[3] 孙旸园,刘 倩,康 蓓.丁苯酞软胶囊联合多巴丝肼片治疗帕金森患者的临床效果[J].临床医学研究与实践,2022,7(14):40-42.
[4] 谷 伟,杨继雷,冯英慧,等.丁苯酞联合脑蛋白水解物治疗老年帕金森病患者的临床疗效及其对免疫功能、神经功能和认知功能的影响[J].临床和实验医学杂志,2022,21(7):706-709.
[5] 彭丽雯.丁苯酞联合多巴丝肼治疗血管性帕金森综合征患者的临床疗效及安全性[J].临床合理用药杂志,2022,15(6):84-86.
[6] 杨一帆,王 豆,李 涛,等.中医药分期治疗卒中后抑郁研究进展[J].陕西中医,2022,43(4):534-537.
[7] 郭文慧,原 景,张 炜.益气活血化痰方治疗慢性阻塞性肺疾病稳定期疗效研究[J].陕西中医,2021,42(6):721-723,738.
[8] 毛 俊,王 柯.SP-D、CXCL13、lncRNA PVT1在老年COPD患者中的表达及与肺功能指标的相关性[J].国际检验医学杂志,2022,43(21):2630-2634.
[9] Jeon D,Chang EG,Mcging M,et al.Pneumoproteins are associated with pulmonary function in HIV-infected persons[J].PLoS One,2019,14(10):e223263.
[10] 蒋凌志,许丹媛,杨志雄.老年COPD患者血清PCT、hs-CRP的表达与肺功能指标、生活质量的相关性[J].中国老年学杂志,2018,38(7):1623-1625.
[11] 郭海燕,林淑芳,梁彩霞,等.血清SP-D、PARC/CCL18水平与慢性阻塞性肺疾病严重程度关系[J].实用医学杂志,2016,32(6):936-938.
[12] Daher A,Dreher M.Oxygen therapy and noninvasive ventilation in chronic obstructive pulmonary disease[J].Clinics in Chest Medicine,2020,41(3):529-545.
[13] Kelly A,Meer OV,Keijzers G,et al.Get with the guidelines:Management of chronic obstructive pulmonary disease in emergency departments in Europe and Australasia is sub-optimal[J].Internal Medicine Journal,2020,50(2):200-208.
[14] Betthauser KD,Eble LN,Juang P,et al.Short-versus standard-course nonmacrolide antibiotic treatment in acute exacerbations of chronic obstructive pulmonary disease:A retrospective,observational cohort study[J].Clinical Therapeutics,2021,43(11):1948-1956.
[15] Park HY,Kang D,Sun HS,et al.Chronic obstructive pulmonary disease and lung cancer incidence in never smokers:A cohort study[J].Thorax,2020,75(6):506-509.
[16] 陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102-104.
[17] Finks SW,Rumbak MJ,Self TH.Treating hypertension in chronic obstructive pulmonary disease[J].New England Journal of Medicine,2020,382(4):353-363.
[18] 李元军.特发性肺间质纤维化临床诊治36例[J].陕西医学杂志,2011,40(7):818-819.
[19] 林 琳,冯 岚,王文尖,等.尿激酶动脉溶栓联合活血化瘀汤对急性脑梗死临床疗效及安全性评价[J].中华中医药学刊,2020,38(11):118-120.
[20] 全紫瑶,陈 菁,武小杰,等.慢性阻塞性肺疾病患者血清S100A8/A9和sRAGE水平变化及临床意义[J].中华检验医学杂志,2020,43(2):165-170.
[21] Papi A,Morandi L,Fabbri LM.Prevention of chronic obstructive pulmonary disease[J].Clinics in Chest Medicine,2020,41(3):453-462.
[22] 明立亮,吴毓霞,吴 勇.纳美芬与纳洛酮联合NPPV治疗COPD并Ⅱ型呼吸衰竭的疗效及对患者肺功能和血气指标的影响[J].湖南师范大学学报:医学版,2021,18(4):282-285.
[23] Pang Q,Li G,Cao F,et al.Clinical efficacy of Chinese herbs for supplementing qi and activating blood circulation combined with N-acetylcysteine in the treatment of idiopathic pulmonary fibrosis:A systematic review and network meta-analysis[J].PLoS One,2022,17(3):e265006.
[24] 杨少敏,刘芝芳.纳美芬联合无创正压机械通气治疗老年COPD合并重症Ⅱ型呼吸衰竭的疗效及对患者血清人Clara细胞分泌蛋白、巨噬细胞刺激蛋白水平的影响研究[J].贵州医药,2021,45(4):516-518.
[25] Yang J,Yuan J,Guan H,et al.Intervention of drug for invigorating blood circulation and eliminating stasis on airway remodeling of COPD rat model[J].Modern Journal of Integrated Traditional Chinese and Western Medicine,2013,53(10):3090-3097.

相似文献/References:

[1]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[2]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
　WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(4):610.
[3]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995.
　LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(4):995.
[4]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
　WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(4):1491.
[5]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57.
　REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(4):57.
[6]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(4):180.
[7]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[8]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534.
　DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(4):534.
[9]唐颖丽,谢 珊,余清萍,等.子午流注法治疗慢性阻塞性肺疾病加重期痰浊阻肺证疗效研究*[J].陕西中医,2020,(9):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
　TANG Yingli,XIE Shan,YU Qingping,et al.Curative effect of midnight-noon ebb-flow method on chronic obstructive pulmonary disease exacerbation with syndrome of Tanzhuo Zufei[J].,2020,(4):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
[10]蔡东林,孙钟和,赵益庆.慢性阻塞性肺疾病稳定期BODE指数、IL-8、TNF-α水平与肺肾气虚证相关性研究*[J].陕西中医,2020,(11):1573.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.015]

备注/Memo

备注/Memo:
基金项目:上海市医学重点专科建设项目(ZK2019C08); 上海市浦东新区临床医学高原学科建设项目(PWYGY2021-09)
更新日期/Last Update: 2023-04-10